节点文献

N-{[(硫色满-4-酮-3-基)-苯基]-甲基}乙酰胺类化合物的合成、α-葡萄糖苷酶抑制活性评价及分子对接研究

Synthesis, biological activity and molecular docking research of N-{[(4-oxo-thiochroman-3-yl)phenyl]-methyl}acetamide derivatives as α-glucosidase inhibitors

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 周冠梁国超韩晓燕钟一凡董芸芳罗晓聪金宏威宋亚丽

【Author】 ZHOU Guan;LIANG Guo-chao;HAN Xiao-yan;ZHONG Yi-fan;DONG Yun-fang;LUO Xiao-cong;JIN Hong-wei;SONG Ya-li;College of Pharmaceutical Sciences, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Hebei University;Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education,Hebei University;Yung Shin Pharm.Ind.(Kunshan) Co., Ltd.;State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University;

【机构】 河北大学药学院河北省药品质量控制重点实验室河北大学药物化学与分子诊断教育部重点实验室永信药品工业(昆山)有限公司北京大学药学院天然药物及仿生药物国家重点实验室

【摘要】 利用Dakin-West反应"一锅法"合成了12个N-{[(硫色满-4-酮-3-基)-苯基]-甲基}乙酰胺衍生物。所合成的化合物经1H NMR、13C NMR、IR和HR-MS等方法进行了结构表征。葡萄糖氧化酶法测试结果表明,大多数目标分子表现出α-葡萄糖苷酶抑制活性,其中化合物4k抑制作用最强(在浓度为5.39 mmol·L-1时,绝对抑制活性达到87.3%)。根据活性测试结果对合成化合物的构效关系进行了讨论。用分子对接方法研究了化合物4k与α-葡萄糖苷酶的作用模式,为进一步的研究提供了依据。

【Abstract】 In order to develop potent antidiabetic agents that have inhibitory effect to α-glucosidase, twelve β-acetamido ketone derivatives such as N-{[(substituted-4-oxo-thiochroman-3-yl)phenyl]-methyl}acetamide are designed and synthesized through one-pot Dakin-West reaction. Their chemical structures are confirmed by 1H NMR, 13 C NMR, IR and HR-MS. In vitro α-glucosidase inhibition assays of compounds 4a-4l were carried out using glucose oxidase method. The result indicated that most of them possess inhibitory activity in vitro. Compound 4k showed the most potent inhibitory activity with 87.3% inhibition of α-glucosidase at the concentration of 5.39 mmol·L-1. The structure-activity relationship of these β-acetamido ketone derivatives was discussed preliminarily. Moreover, the molecular docking method was used to study the interaction mode of compound 4k and α-glucosidase. Our results will be helpful for designing of α-glucosidase inhibitors in the future.

【基金】 河北大学自然科学基金资助项目(2010-194);河北省药物质量分析控制重点实验室开放基金资助课题
  • 【文献出处】 药学学报 ,Acta Pharmaceutica Sinica , 编辑部邮箱 ,2016年01期
  • 【分类号】R914.5;R96
  • 【被引频次】4
  • 【下载频次】316
节点文献中: 

本文链接的文献网络图示:

本文的引文网络